Recorded February 23, 2022. Noble Capital Markets Senior Research Analyst Gregory Aurand sits down with Baudax Bio President & CEO Gerri Henwood for this exclusive interview. Topics covered include:An overview of Baudax Bio and their product profileHow are Anjeso commercial activities progressing? Has Covid shifted the strategy?What proposed CDC opioid guidelines mean for BaudaxLong term opportunities for neuromuscular blocking agentsDoes the recent stock split cure the Nasdaq difficiency?What will get the stock moving in the right direction going forward? Read More >>